Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

First-trimester detection of fetal anomalies in pregestational diabetes using nuchal translucency, ductus venosus Doppler, and maternal glycosylated hemoglobin.

Miller JL, de Veciana M, Turan S, Kush M, Manogura A, Harman CR, Baschat AA.

Am J Obstet Gynecol. 2013 May;208(5):385.e1-8. doi: 10.1016/j.ajog.2013.01.041. Epub 2013 Jan 24.

PMID:
23353022
2.

[The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].

Baś-Budecka E, Perenc M, Sieroszewski P.

Ginekol Pol. 2010 Apr;81(4):272-6. Polish.

PMID:
20476599
3.

[Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].

Yang Y, Zhang Y.

Zhonghua Fu Chan Ke Za Zhi. 2014 Mar;49(3):188-92. Chinese.

PMID:
24820303
4.
5.

Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.

Martínez JM, Comas M, Borrell A, Bennasar M, Gómez O, Puerto B, Gratacós E.

Ultrasound Obstet Gynecol. 2010 Mar;35(3):267-72. doi: 10.1002/uog.7544.

6.
7.

First-trimester detection of major cardiac defects with the use of ductus venosus blood flow.

Borrell A, Grande M, Bennasar M, Borobio V, Jimenez JM, Stergiotou I, Martinez JM, Cuckle H.

Ultrasound Obstet Gynecol. 2013 Jul;42(1):51-7. doi: 10.1002/uog.12349.

8.

The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.

Favre R, Cherif Y, Kohler M, Kohler A, Hunsinger MC, Bouffet N, Tanghe M, Cancellier M, Nisand I.

Ultrasound Obstet Gynecol. 2003 Mar;21(3):239-43.

9.

The role of ductus venosus Doppler flow in the diagnosis of chromosomal abnormalities during the first trimester of pregnancy.

Florjański J, Fuchs T, Zimmer M, Homola W, Pomorski M, Blok D.

Adv Clin Exp Med. 2013 May-Jun;22(3):395-401.

10.

Decreased fetal cardiac performance in the first trimester correlates with hyperglycemia in pregestational maternal diabetes.

Turan S, Turan OM, Miller J, Harman C, Reece EA, Baschat AA.

Ultrasound Obstet Gynecol. 2011 Sep;38(3):325-31. doi: 10.1002/uog.9035. Epub 2011 Aug 10.

11.

Contribution of ductus venosus Doppler in first-trimester screening for major cardiac defects.

Chelemen T, Syngelaki A, Maiz N, Allan L, Nicolaides KH.

Fetal Diagn Ther. 2011;29(2):127-34. doi: 10.1159/000322138. Epub 2010 Dec 16.

12.

Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: relationship with nuchal translucency measurement and fetal outcome.

Bilardo CM, Müller MA, Zikulnig L, Schipper M, Hecher K.

Ultrasound Obstet Gynecol. 2001 Apr;17(4):288-94.

13.

[Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].

Ducarme G, Graesslin O, Alanio E, Bige V, Gaillard D, Gabriel R.

Gynecol Obstet Fertil. 2005 Oct;33(10):750-4. French.

PMID:
16139544
14.

Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus.

Mavrides E, Sairam S, Hollis B, Thilaganathan B.

BJOG. 2002 Sep;109(9):1015-9.

15.

Obstetric outcomes in pregnancies with normal nuchal translucency and abnormal ductus venosus Doppler in the first trimester ultrasonography.

Seckin KD, Karslı MF, Baser E, Yeral MI, Tasin C, Ozgu Erdinc AS, Danisman N.

J Obstet Gynaecol. 2016 May;36(4):440-3. doi: 10.3109/01443615.2015.1060210. Epub 2015 Oct 12.

PMID:
26457755
16.

Ductus venosus pulsatility index measurement reduces the false-positive rate in first-trimester screening.

Timmerman E, Oude Rengerink K, Pajkrt E, Opmeer BC, van der Post JA, Bilardo CM.

Ultrasound Obstet Gynecol. 2010 Dec;36(6):661-7. doi: 10.1002/uog.7706. Epub 2010 Jun 2.

17.

Screening performances of abnormal first-trimester ductus venosus blood flow and increased nuchal translucency thickness in detection of major heart defects.

Karadzov-Orlic N, Egic A, Filimonovic D, Damnjanovic-Pazin B, Milovanovic Z, Lukic R, Mandic V, Joksic I, Vukomanovic V, Kosutic J, Djuricic S, Mikovic Z.

Prenat Diagn. 2015 Dec;35(13):1308-15. doi: 10.1002/pd.4693. Epub 2015 Oct 12.

PMID:
26408089
18.

First-trimester measurement of the ductus venosus pulsatility index and the prediction of congenital heart defects.

Timmerman E, Clur SA, Pajkrt E, Bilardo CM.

Ultrasound Obstet Gynecol. 2010 Dec;36(6):668-75. doi: 10.1002/uog.7742. Epub 2010 Jul 8.

19.

A preliminary retrospective study about the relationship between ductus venosus Doppler indices, nuchal translucency (NT) and biochemical markers in the first and second trimester screening tests.

Demirturk F, Caliskan AC, Aytan H, Sahin S.

Gynecol Endocrinol. 2012 May;28(5):378-81. doi: 10.3109/09513590.2011.631633. Epub 2012 Feb 27.

PMID:
22364171
20.

Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness.

Maiz N, Plasencia W, Dagklis T, Faros E, Nicolaides K.

Ultrasound Obstet Gynecol. 2008 Mar;31(3):256-60. doi: 10.1002/uog.5262.

Supplemental Content

Support Center